Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide



Veerapen et al.


Page 6


Sponsored Document            Sponsored Document            Sponsored Document


4. Hong S. Scherer D.C. Mendiratta S.K. Serizawa I. Koezuka Y. Van K.L. Immunol. Rev. 1997;169:31.
[PubMed: 10450506]

5. Kawano T. Cui J. Koezuka Y. Toura I. Kaneko Y. Motoki K. Ueno H. Nakagawa R. Sato H. Kondo
E. Koseki H. Taniguchi M. Science 1997;278:1626. [PubMed: 9374463]

6. Crowe N. Uldrich A.P. Kyparissoudis K. Hammond K.J.L. Hayakawa Y. Sidobre S. Keating R.
Kronenberg M. Smyth M.J. Godfrey D.I. J. Immunol. 2003;171:4020. [PubMed: 14530322]

7. Burdin N. Brossay L. Kronenberg M. Eur. J. Immunol. 1999;29:2014. [PubMed: 10382765]

8. Carnaud C. Lee D. Donnars O. Park S.H. Beavis A. Koezuka Y. Bendelac A. J. Immunol.

1999;163:4647. [PubMed: 10528160]

9. Taniguchi M. Harada M. Kojo S. Nakayama T. Wakao H. Annu. Rev. Immnunol. 2003;21:483.

10. Godfrey D.I. MacDonald H.R. Kronenberg M. Smyth M.J. Van K.L. Nat. Rev. Immunol. 2004;4:231.
[PubMed: 15039760]

11. Gonzalez-Aseguinolaza G. Van Kaer L. Bergmann C.C. Wilson J.M. Schmieg J. Kronenberg M.
Nakayama T. Taniguchi M. Koezuka Y. Tsuji M. J. Exp. Med. 2002;195:617. [PubMed: 11877484]

12. Miyamoto K. Miyake S. Yamamura T. Nature 2001;413:513.

13. Chiba A. Oki S. Miyamoto K. Hashimoto H. Yamamura T. Miyake S. Arthritis Rheum. 2004;50:305.
[PubMed: 14730629]

14. (a) Takikawa H. Muto S.E. Mori K. Tetrahedron 1998;54:3141. (b) Figueroa-Perez S. Schmidt R.R.
Carbohydr. Res. 2000;328:95. [PubMed: 11028777] (c) Xia C. Yao Q. Schuemann J. Rossy E. Chen
W. Zhu L. Zhang W. De Libero G. Wang P.G. Bioorg. Med. Chem. Lett. 2006;16:2195. [PubMed:
16458002] (d) Fan G.T. Pan Y.S. Lu K.C. Cheng Y.P. Lin W.C. Lin S. Lin C.H. Wong C.H. Fang
J.M. Lin C.C. Tetrahedron 2005;61:1855. (e) Ndonye R.M. Izmirian D.P. Dunn M.F. Yu K.O.A.
Porcelli S.A. Khurana A. Kronenberg M. Richardson S.K. Howell A.R. J. Org. Chem.

2005;70:10260. [PubMed: 16323834] (f) Michieletti M. Bracci A. Compostella F. De Libero G. Mori
L. Fallarini S. Lombardi G. Panza L. J. Org. Chem. 2008;73:9192. [PubMed: 18956839] (g) Lee A.
Farrand K.J. Dickgreber N. Hayman C.M. Juers S. Hermans I.F. Painter G.F. Carbohydr. Res.

2006;341:2785. [PubMed: 17014832]

15. Kimura A. Imamura A. Ando H. Ishida H. Kiso M. Synlett 2006;15:2379.

16. Akimoto K. Natori T. Morita M. Tetrahedron Lett. 1993;34:5593.

17. Van den Berg R.J.B.H.N. Boltje T.J. Verhagen C.P. Litjens R.E.J.N. Van der Marel G.A. Overkleeft
H.S. J. Org. Chem. 2006;71:836. [PubMed: 16409007]

18. Imamura A. Ando H. Korogi S. Tanabe G. Muraoka O. Ishida H. Kiso M. Tetrahedron Lett.
2003;44:6725.

19. Hada N. Oka J. Nishiyama A. Takeda T. Tetrahedron Lett. 2006;47:6647.

20. (a) Stork G. Kim G. J. Am. Chem. Soc. 1992;114:1087. (b) Bols M. J. Chem. Soc., Chem. Commun.
1992;12:913. (c) Bols M. J. Chem. Soc., Chem. Commun. 1993;9:791. (d) Bols M. Acta Chem.
Scand. 1993;47:829.

21. Bols M. Tetrahedron 1993;49:10049.

22. Saito S. Ichinose K. Sasaki Y. Sumita S. Chem. Pharm. Bull. 1992;40:3261. [PubMed: 1294329]

23. Prigozy T.I. Naidenko O. Qasba P. Elewaut D. Brossay L. Khurana A. Natori T. Koezuka Y. Kulkarni
A. Kronenberg M. Science 2001;291:664. [PubMed: 11158680]

24. Kinjo Y. Pei B. Bufali S. Raju R. Richardson Stewart K. Imamura M. Fujio M. Wu D. Khurana A.
Kawahara K. Wong C.H. Howell A.R. Seeberger P.H. Kronenberg M. Chem. Biol. 2008;15:654.
[PubMed: 18635002]and references therein

25. (a) Brigl M. Bry L. Kent S.C. Gumperz J.E. Brenner M.B. Nat. Immunol. 2003;4:1230. [PubMed:
14578883] (b) Gumperz J.E. Roy C. Makowska A. Lum D. Sugita M. Podrebarac T. Koezuka Y.
Porcelli S.A. Cardell S. Brenner M.B. Behar S.M. Immunity 2000;12:211. [PubMed: 10714687] (c)
Sugita M. van Der Wel N. Rogers R.A. Peters P.J. Brenner M.B. Proc. Natl. Acad. Sci. U.S.A.
2000;97:8445. [PubMed: 10890914]

26. Selected data for new compounds6: 1H NMR (CDCl3): δ 7.92-8.04 (10H, m, Ar-H), 7.27-7.64 (10H,
m, Ar-
H), 5.80 (1H, dd, H-2, J2,1 = 3.6), 5.55 (1H, dd, J3,2 = 10.6, J3,4 = 2.8 Hz, H-3), 5.42-5.50
(2H, m, H-3
Cer, H-4Cer), 5.31 (1H, d, H-1), 4.87 (d, 1H, H-4), 4.13-4.27 (m, 3H, H-2Cer, H-6a,,
H-6b), 4.00-4.13 (m, 1H, H-5), 3.85-3.90 (m, 1H, H-1a
Cer), 3.68 (dd, 1H, J1a,1b = 10.4, J1b,

Published as: Bioorg Med Chem Lett. 2009 August 01; 19(15): 4288-4291.



More intriguing information

1. Alzheimer’s Disease and Herpes Simplex Encephalitis
2. Cross-Country Evidence on the Link between the Level of Infrastructure and Capital Inflows
3. The name is absent
4. Studying How E-Markets Evaluation Can Enhance Trust in Virtual Business Communities
5. The Macroeconomic Determinants of Volatility in Precious Metals Markets
6. The name is absent
7. Gerontocracy in Motion? – European Cross-Country Evidence on the Labor Market Consequences of Population Ageing
8. Three Strikes and You.re Out: Reply to Cooper and Willis
9. An alternative way to model merit good arguments
10. The name is absent
11. Herman Melville and the Problem of Evil
12. Cyclical Changes in Short-Run Earnings Mobility in Canada, 1982-1996
13. Input-Output Analysis, Linear Programming and Modified Multipliers
14. CONSUMER PERCEPTION ON ALTERNATIVE POULTRY
15. EDUCATIONAL ACTIVITIES IN TENNESSEE ON WATER USE AND CONTROL - AGRICULTURAL PHASES
16. Psychological Aspects of Market Crashes
17. Insecure Property Rights and Growth: The Roles of Appropriation Costs, Wealth Effects, and Heterogeneity
18. Long-Term Capital Movements
19. The ultimate determinants of central bank independence
20. The Making of Cultural Policy: A European Perspective